This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Giakkoupi, P.
Right arrow Articles by Vatopoulos, A. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giakkoupi, P.
Right arrow Articles by Vatopoulos, A. C.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, August 2003, p. 3893-3896, Vol. 41, No. 8
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.8.3893-3896.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

VIM-1 Metallo-ß-Lactamase-Producing Klebsiella pneumoniae Strains in Greek Hospitals

P. Giakkoupi,1 A. Xanthaki,2 M. Kanelopoulou,3 A. Vlahaki,4 V. Miriagou,5 S. Kontou,2 E. Papafraggas,3 H. Malamou-Lada,4 L. S. Tzouvelekis,6 N. J. Legakis,6 and A. C. Vatopoulos1*

Departments of Hygiene and Epidemiology,1 Microbiology, Medical School, University of Athens,6 Hippokration General Hospital,2 Sismanoglio General Hospital,3 G. Genimatas General Hospital,4 Laboratory of Bacteriology, Hellenic Pasteur Institute, Athens, Greece5

Received 3 March 2003/ Returned for modification 18 April 2003/ Accepted 15 May 2003


arrow
ABSTRACT
 
Seventeen Klebsiella pneumoniae clinical isolates carrying the blaVIM-1 metallo-ß-lactamase gene were collected in the intensive care units of three hospitals in Athens, Greece, in 2002. They exhibited various carbapenem resistance levels (Etest MICs of imipenem ranged from 4 to 32 µg/ml). All isolates gave positive results by the imipenem-EDTA synergy Etest. The isolates were classified into four main types by pulsed-field gel electrophoresis; the majority of the isolates (5 and 10 isolates) belonged to two types. The blaVIM-1 gene cassette was part of the variable region of a class 1 integron that also included aac6, dhfrI, and aadA. This structure was carried by transferable plasmids.


arrow
TEXT
 
The metallo-ß-lactamases (MBLs) of the IMP and VIM types are increasingly important clinically. These enzymes are active against most ß-lactams, including carbapenems, and have been found in various gram-negative clinical isolates mostly in the Far East and the Mediterranean region (12). The wide spread of integron-borne blaVIM genes in Pseudomonas aeruginosa strains in Greek hospitals has been documented (2, 9, 16). Additionally, a sporadic strain of Escherichia coli exhibiting resistance to imipenem due to production of a plasmid-mediated VIM-1 MBL was recently isolated in a Greek hospital (10). In the present study, we describe VIM-1-producing Klebsiella pneumoniae clinical strains isolated in three hospitals in Athens, Greece.

Seventeen K. pneumoniae clinical isolates were studied. They were derived from patients hospitalized from September to December 2002 in the intensive care units of three teaching hospitals (I, II, and III) located in Athens, Greece (Table 1). At least 12 of the isolates were considered causes of infection. Isolates were retained in the respective hospital laboratories because they exhibited resistance or decreased susceptibility to imipenem (a MIC of >=8 µg/ml or an inhibition zone of <16 mm in diameter by the disk diffusion test) using the automated systems VITEK 2 (bioMerieux S.A.) (hospital I) and Wider I (Francisco Soria Melguizo S.A.) (hospital II) and the disk diffusion test (11) (hospital III).


View this table:
[in this window]
[in a new window]
  		TABLE 1. Characteristics of 17 blaVIM-1-containing K. pneumoniae clinical isolates and 6 E. coli transconjugants

Species identification was confirmed by using API 20E strips (bioMerieux). MICs of ß-lactams were determined by the Etest (AB Biodisk). Susceptibility to other antimicrobial agents was assessed by the disk diffusion test (11). The Etest strip containing imipenem plus EDTA was used to detect MBL production.

Typing was performed by pulsed-field gel electrophoresis (PFGE) of XbaI-restricted genomic DNA as described previously (1). Restriction fragments were separated through a 1% agarose gel using a contour-clamped homogeneous electric field DRIII apparatus (Bio-Rad). Classification of the isolates into PFGE types was based on the criteria proposed by Tenover et al. (15).

Conjugal transfer of antibiotic resistance was performed in mixed broth cultures as described previously (17) using the E. coli strain 14R (Nalr lac) as a recipient. Transconjugant clones were selected in Mueller-Hinton agar containing nalidixic acid (100 µg/ml) plus ampicillin (50 µg/ml). Plasmid DNA preparations obtained by an alkaline lysis technique (13) were digested with PstI and electrophoresed in 0.8% agarose gels.

VIM-type genes were detected by PCR using primers VIM-F (5'-AGTGGTGAGTATCCGACAG-3') and VIM-R (5'-ATGAAAGTGCGTGGAGAC-3') corresponding to nucleotides 1339 to 1357 and 1599 to 1582, respectively, of the blaVIM-1 integron (6) (GenBank accession no. Y18050). These primers were also used to amplify a 261-bp blaVIM-1 fragment from the E. coli plasmid p541 (10). The 261-bp blaVIM-1 fragment was labeled with digoxigenin with commercially available reagents (Roche Diagnostics) and used as a blaVIM-1 probe in hybridization experiments. Mapping of class 1 integrons was performed by PCR using primers 5'CS and 3'CS (7) and a set of primers specific for various resistance genes, including aacA, dhfrI, and aadA. Nucleotide sequences of the PCR products were determined on both strands with an ABI Prism 377 DNA sequencer (Applied Biosystems).

Determination of imipenem MICs with the Etest confirmed the results reported from the hospital laboratories for 13 of the 17 isolates. The remaining four isolates (Kp5, Kp11, Kp15, and Kp16), however, exhibited an imipenem Etest MIC equal to 4 µg/ml, which is within the susceptibility range. The possible causes of this discrepancy were not investigated. All the isolates examined were multidrug resistant. MICs of imipenem ranged from 4 to 32 µg/ml. In four isolates, the MICs of imipenem were two or more doubling dilutions higher than those of meropenem. In one isolate, the MIC of meropenem exceeded that of imipenem. The MICs of other ß-lactams also varied. Seven isolates were highly resistant to aztreonam, while the MICs of aztreonam were significantly lower for the remaining isolates. The isolates were also resistant to various non-ß-lactam antibiotics, including aminoglycosides, co-trimoxazole, and chloramphenicol (Table 1). Ciprofloxacin was active against all 17 isolates.

Results of the imipenem-EDTA synergy tests indicated that all 17 isolates produced MBLs. In 10 isolates, a phantom zone of inhibition between the two gradient sections of the imipenem-EDTA Etest strip was considered a positive result (18).

The isolates were classified into four main types (A to D) by analyzing the results of PFGE. Five of six isolates from hospital I exhibited highly similar PFGE patterns (type A). Chromosomal type C accounted for the majority of the isolates from hospitals II and III. Types B and D were represented by one isolate each (Table 1 and Fig. 1).



View larger version (107K):
[in this window]
[in a new window]
  		FIG. 1. PFGE patterns of K. pneumoniae isolates carrying VIM-type MBL genes. Lanes 1 and 2, isolates Kp1 and Kp2 (pattern A); lane 3, isolate Kp5 (pattern B); lane 4, isolate Kp6 (pattern A); lanes 5 and 6, isolates Kp7 and Kp8 (pattern C); lane 7, isolate Kp11 (pattern C1); lane 8, isolate Kp12 (pattern D); lanes 9 and 10, isolates Kp13 and Kp16 (pattern C).

Conjugal transfer of resistance was attempted with seven isolates representing the three hospitals and three PFGE types (A, B, and C). blaVIM-positive transconjugants were obtained from all but one isolate (Kp5, PFGE type B). Carbapenem resistance levels were significantly lower in the E. coli clones than in the donors (Table 1). Cotransfer of resistance to non-ß-lactams was also observed, indicating involvement of multiresistant plasmids. Results of plasmid DNA analysis were in line with the typing results. The plasmids derived from isolates Kp1 and Kp2 (PFGE type A) were similar (plasmid type 1). Similar plasmids were also obtained from the PFGE type C isolates Kp8, Kp11, Kp13, and Kp16 (plasmid type 2). These two plasmid species were similar in size (approximately 50 kb) but exhibited different restriction profiles (Fig. 2A). In the digests of both plasmid types, a band (approximately 7.5 kbp for type 1 and 5 kbp for type 2) hybridized with the blaVIM-1 probe (Fig. 2B).



View larger version (55K):
[in this window]
[in a new window]
  		FIG. 2. (A) PstI restriction profiles of the blaVIM-1-carrying plasmids extracted from E. coli transconjugants trc-1, trc-2 (plasmid type 1), trc-8, and trc-13 (plasmid type 2) are presented in lanes 1 to 4, respectively. (B) Hybridization of the preparations shown in panel A with a blaVIM-1 probe.

Integron mapping of seven K. pneumoniae isolates and the respective E. coli transconjugants by PCR (Table 1) indicated a common class 1 integron structure. The cassette region was approximately 3 kb in size and contained (from 5' to 3') blaVIM-1, aac6, dhfrI, and aadA. DNA sequencing of various overlapping PCR amplicons from isolates Kp1, Kp8, and Kp16 and the respective E. coli transconjugants showed that the aatI1 site of this class 1 integron was followed by blaVIM-1. The blaVIM-1 cassette (including the 59-base element) was identical to the one in P. aeruginosa described previously (6) (GenBank accession no. Y18050) and E. coli (10).

The potential of IMP and VIM MBL genes to spread among clinical enterobacteria has also been shown previously (3-5, 14, 19-21). The results of this study, along with the recent isolation of a VIM-1-producing E. coli (10), indicate that VIM-type genes have been spread via transferable plasmids in the enterobacteria of the hospital flora in Greece. Also, acquisition of the VIM-1 integrons by distinct plasmids suggests a possible association with mobile elements. Therefore, containment of this resistance is expected to be difficult.

Decreased susceptibility to imipenem allowed recognition of the VIM-producing K. pneumoniae isolates in the hospital laboratories. Consequently, infection control measures, including isolation of these patients, were applied in a timely fashion. These measures probably accounted for the apparent decrease in the isolation frequency of imipenem-resistant K. pneumoniae strains, as indicated in the records of the three hospitals since January 2003. Typing results suggested spread of a limited number of strains. There were, however, substantial differences in the ß-lactam resistance levels between isolates of the same chromosomal type. For instance, isolate Kp16 was resistant to aztreonam, while the rest of the type C isolates were susceptible to this antibiotic. It can be hypothesized that the similarity of the PFGE patterns reflected, in some cases, strains of common origin that evolved over time.

The isolates examined may represent a portion of the blaVIM-1-containing strains circulating in these hospitals. MBL production in enterobacteria may not be able to substantially increase the MICs of carbapenems without the simultaneous operation of other mechanisms such as impaired permeability (5, 8). The differences in the imipenem MICs of the clinical isolates and transconjugants are compatible with this notion. Thus, a number of MBL-producing strains may pass unnoticed in routine susceptibility testing. Also, the imipenem-EDTA Etest strip may exhibit low sensitivity for MBL-producing enterobacteria with imipenem MICs lower than those observed here. Additionally, detection of MBL-producing enterobacteria may pose technical difficulties. As has been shown for MBL-producing nonfermenters, the composition of the medium significantly affects the MICs of carbapenems; this effect may be due to differences in zinc concentration (18). This could partly explain the discrepancies between the Etest and the methods employed in the hospitals. Therefore, standardization and evaluation of the performance of the susceptibility tests for MBL-producing enterobacteria are required.


arrow
ACKNOWLEDGMENTS
 
This work was supported by the Hellenic Centre for Infectious Disease Control (KEEL, Ministry of Health).

We thank Argiro Meni for excellent technical assistance and Kostas Gogoglou for his help.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Department of Hygiene and Epidemiology, Medical School, Athens University, M. Asias 75, Athens 11527, Greece. Phone: 30.2107462071. Fax: 30.2107462080. E-mail: avatopou{at}med.uoa.gr. Back


arrow
REFERENCES
 
    1
  1. Gautom, R. K. 1997. Rapid pulsed-field gel electrophoresis protocol for typing of Escherichia coli O157:H7 and other gram-negative organisms in 1 day. J. Clin. Microbiol. 35:2977-2980.[Abstract]
    2. 2
  2. Giakkoupi, P., G. Petrikkos, L. S. Tzouvelekis, S. Tsonas, The WHONET GREECE Study Group, N. J. Legakis, and A. C. Vatopoulos. 2003. Spread of integron-associated VIM-type metallo-ß-lactamase genes among imipenem-nonsusceptible Pseudomonas aeruginosa strains in Greek hospitals. J. Clin. Microbiol. 41:822-825.[Abstract/Free Full Text]
    3. 3
  3. Hawkey, P. M., J. Xiong, H. Ye, H. Li, and F. H. M'Zali. 2001. Occurrence of a new metallo-beta-lactamase IMP-4 carried on a conjugative plasmid in Citrobacter youngae from the People's Republic of China. FEMS Microbiol. Lett. 194:53-57.[Medline]
    4. 4
  4. Jeong, S. H., K. Lee, Y. Chong, J. H. Yum, S. H. Lee, H. J. Choi, J. M. Kim, K. H. Park, B. H. Han, S. W. Lee, and T. S. Jeong. 2003. Characterization of a new integron containing VIM-2, a metallo-ß-lactamase gene cassette, in a clinical isolate of Enterobacter cloacae. J. Antimicrob. Chemother. 51:397-400.[Abstract/Free Full Text]
    5. 5
  5. Koh, T. H., L.-H. Sng, G. S. Babini, N. Woodford, D. M. Livermore, and L. M. C. Hall. 2001. Carbapenem-resistant Klebsiella pneumoniae in Singapore producing IMP-1 ß-lactamase and lacking an outer membrane protein. Antimicrob. Agents Chemother. 45:1939-1940.[Free Full Text]
    6. 6
  6. Lauretti, L., M. L. Riccio, A. Mazzariol, G. Cornaglia, G. Amicosante, R. Fontana, and G. M. Rossolini. 1999. Cloning and characterization of blaVIM, a new integron-borne metallo-ß-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob. Agents Chemother. 43:1584-1590.[Abstract/Free Full Text]
    7. 7
  7. Levesque, C., L. Piche, C. Larose, and P. H. Roy. 1995. PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob. Agents Chemother. 39:185-191.[Abstract]
    8. 8
  8. Livermore, D. M., K. J. Oakton, M. W. Carter, and M. Warner. 2001. Activity of ertapenem (MK-0826) versus Enterobacteriaceae with potent ß-lactamases. Antimicrob. Agents Chemother. 45:2831-2837.[Abstract/Free Full Text]
    9. 9
  9. Mavroidi, A., A. Tsakris, E. Tzelepi, S. Pournaras, V. Loukova, and L. S. Tzouvelekis. 2000. Carbapenem-hydrolysing VIM-2 metallo-ß-lactamase in Pseudomonas aeruginosa from Greece. J. Antimicrob. Chemother. 46:1041-1042.[Free Full Text]
    10. 10
  10. Miriagou, V., E. Tzelepi, D. Gianneli, and L. S. Tzouvelekis. 2003. Escherichia coli with a self-transferable, multiresistant plasmid coding for metallo-ß-lactamase VIM-1. Antimicrob. Agents Chemother. 47:395-397.[Abstract/Free Full Text]
    11. 11
  11. National Committee for Clinical Laboratory Standards. 1999. Performance standards for antimicrobial disk susceptibility tests, 6th ed. Approved standard M2-A6 (M100-S7). National Committee for Clinical Laboratory Standards, Wayne, Pa.
    12. 12
  12. Nordmann, P., and L. Poirel. 2002. Emerging carbapenemases in Gram-negative aerobes. Clin. Microbiol. Infect. 8:321-331.[CrossRef][Medline]
    13. 13
  13. Portnoy, D. A., S. L. Moseley, and S. Falkow. 1981. Characterization of plasmids and plasmid-associated determinants of Yersinia enterocolitica pathogenesis. Infect. Immun. 31:775-782.[Abstract/Free Full Text]
    14. 14
  14. Senda, K., Y. Arakawa, S. Ichiyama, K. Nakashima, H. Ito, S. Ohsuka, K. Shimokata, N. Kato, and M. Ohta. 1996. PCR detection of metallo-ß-lactamase gene (blaIMP) in gram-negative rods resistant to broad-spectrum ß-lactams. J. Clin. Microbiol. 34:2909-2913.[Abstract]
    15. 15
  15. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Michelsen, B. A. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.[Medline]
    16. 16
  16. Tsakris, A., S. Pournaras, N. Woodford, M.-F. I. Palepou, G. S. Babini, J. Douboyas, and D. M. Livermore. 2000. Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece. J. Clin. Microbiol. 38:1290-1292.[Abstract/Free Full Text]
    17. 17
  17. Vatopoulos, A. C., A. Philippon, L. S. Tzouvelekis, Z. Komninou, and N. J. Legakis. 1990. Prevalence of a transferable SHV-5 type ß-lactamase in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Greece. J. Antimicrob. Chemother. 26:635-648.[Abstract/Free Full Text]
    18. 18
  18. Walsh, T. R., A. Bolmstrom, A. Qwarnstrom, and A. Gales. 2002. Evaluation of a new Etest for detecting metallo-ß-lactamases in routine clinical testing. J. Clin. Microbiol. 40:2755-2759.[Abstract/Free Full Text]
    19. 19
  19. Yan, J.-J., W.-C. Ko, C.-L. Chuang, and J.-J. Wu. 2002. Metallo-lactamase-producing Enterobacteriaceae isolates in a university hospital in Taiwan: prevalence of IMP-8 in Enterobacter cloacae and first identification of VIM-2 in Citrobacter freundii. J. Antimicrob. Chemother. 50:503-511.[Abstract/Free Full Text]
    20. 20
  20. Yan, J.-J., W.-C. Ko, S.-H. Tsai, H.-M. Wu, and J.-J. Wu. 2001. Outbreak of infection with multidrug-resistant Klebsiella pneumoniae carrying blaIMP-8 in a university medical center in Taiwan. J. Clin. Microbiol. 39:4433-4439.[Abstract/Free Full Text]
    21. 21
  21. Yum, J. H., D. Yong, K. Lee, H. S. Kim, and Y. Chong. 2002. A new integron carrying VIM-2 metallo-beta-lactamase gene cassette in a Serratia marcescens isolate. Diagn. Microbiol. Infect. Dis. 42:217-219.[CrossRef][Medline]

Journal of Clinical Microbiology, August 2003, p. 3893-3896, Vol. 41, No. 8
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.8.3893-3896.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Lim, K. T., Yeo, C. C., Md Yasin, R., Balan, G., Thong, K. L. (2009). Characterization of multidrug-resistant and extended-spectrum {beta}-lactamase-producing Klebsiella pneumoniae strains from Malaysian hospitals. J Med Microbiol 58: 1463-1469 [Abstract] [Full Text]  
  • Daikos, G. L., Petrikkos, P., Psichogiou, M., Kosmidis, C., Vryonis, E., Skoutelis, A., Georgousi, K., Tzouvelekis, L. S., Tassios, P. T., Bamia, C., Petrikkos, G. (2009). Prospective Observational Study of the Impact of VIM-1 Metallo-{beta}-Lactamase on the Outcome of Patients with Klebsiella pneumoniae Bloodstream Infections. Antimicrob. Agents Chemother. 53: 1868-1873 [Abstract] [Full Text]  
  • Li, H., Toleman, M. A., Bennett, P. M., Jones, R. N., Walsh, T. R. (2008). Complete Sequence of p07-406, a 24,179-Base-Pair Plasmid Harboring the blaVIM-7 Metallo-{beta}-Lactamase Gene in a Pseudomonas aeruginosa Isolate from the United States. Antimicrob. Agents Chemother. 52: 3099-3105 [Abstract] [Full Text]  
  • Giske, C. G., Monnet, D. L., Cars, O., Carmeli, Y., on behalf of ReAct-Action on Antibiotic Resistance, (2008). Clinical and Economic Impact of Common Multidrug-Resistant Gram-Negative Bacilli. Antimicrob. Agents Chemother. 52: 813-821 [Full Text]  
  • Galani, I., Rekatsina, P. D., Hatzaki, D., Plachouras, D., Souli, M., Giamarellou, H. (2008). Evaluation of different laboratory tests for the detection of metallo-{beta}-lactamase production in Enterobacteriaceae. J Antimicrob Chemother 61: 548-553 [Abstract] [Full Text]  
  • Schwaber, M. J., Klarfeld-Lidji, S., Navon-Venezia, S., Schwartz, D., Leavitt, A., Carmeli, Y. (2008). Predictors of Carbapenem-Resistant Klebsiella pneumoniae Acquisition among Hospitalized Adults and Effect of Acquisition on Mortality. Antimicrob. Agents Chemother. 52: 1028-1033 [Abstract] [Full Text]  
  • Tokatlidou, D., Tsivitanidou, M., Pournaras, S., Ikonomidis, A., Tsakris, A., Sofianou, D. (2008). Outbreak Caused by a Multidrug-Resistant Klebsiella pneumoniae Clone Carrying blaVIM-12 in a University Hospital. J. Clin. Microbiol. 46: 1005-1008 [Abstract] [Full Text]  
  • Cagnacci, S., Gualco, L., Roveta, S., Mannelli, S., Borgianni, L., Docquier, J.-D., Dodi, F., Centanaro, M., Debbia, E., Marchese, A., Rossolini, G. M. (2008). Bloodstream infections caused by multidrug-resistant Klebsiella pneumoniae producing the carbapenem-hydrolysing VIM-1 metallo-{beta}-lactamase: first Italian outbreak. J Antimicrob Chemother 61: 296-300 [Abstract] [Full Text]  
  • Psichogiou, M., Tassios, P. T., Avlamis, A., Stefanou, I., Kosmidis, C., Platsouka, E., Paniara, O., Xanthaki, A., Toutouza, M., Daikos, G. L., Tzouvelekis, L. S. (2008). Ongoing epidemic of blaVIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey. J Antimicrob Chemother 61: 59-63 [Abstract] [Full Text]  
  • Ikonomidis, A., Labrou, M., Afkou, Z., Maniatis, A. N., Sofianou, D., Tsakris, A., Pournaras, S. (2007). First Occurrence of an Escherichia coli Clinical Isolate Producing the VIM-1/VIM-2 Hybrid Metallo-{beta}-Lactamase VIM-12. Antimicrob. Agents Chemother. 51: 3038-3039 [Full Text]  
  • Queenan, A. M., Bush, K. (2007). Carbapenemases: the Versatile {beta}-Lactamases. Clin. Microbiol. Rev. 20: 440-458 [Abstract] [Full Text]  
  • Galani, I., Souli, M., Koratzanis, E., Koratzanis, G., Chryssouli, Z., Giamarellou, H. (2007). Emerging bacterial pathogens: Escherichia coli, Enterobacter aerogenes and Proteus mirabilis clinical isolates harbouring the same transferable plasmid coding for metallo-{beta}-lactamase VIM-1 in Greece. J Antimicrob Chemother 59: 578-579 [Full Text]  
  • Ktari, S., Arlet, G., Mnif, B., Gautier, V., Mahjoubi, F., Ben Jmeaa, M., Bouaziz, M., Hammami, A. (2006). Emergence of Multidrug-Resistant Klebsiella pneumoniae Isolates Producing VIM-4 Metallo-{beta}-Lactamase, CTX-M-15 Extended-Spectrum {beta}-Lactamase, and CMY-4 AmpC {beta}-Lactamase in a Tunisian University Hospital. Antimicrob. Agents Chemother. 50: 4198-4201 [Abstract] [Full Text]  
  • Giske, C. G., Libisch, B., Colinon, C., Scoulica, E., Pagani, L., Fuzi, M., Kronvall, G., Rossolini, G. M. (2006). Establishing Clonal Relationships between VIM-1-Like Metallo-{beta}-Lactamase-Producing Pseudomonas aeruginosa Strains from Four European Countries by Multilocus Sequence Typing. J. Clin. Microbiol. 44: 4309-4315 [Abstract] [Full Text]  
  • Kaczmarek, F. M., Dib-Hajj, F., Shang, W., Gootz, T. D. (2006). High-Level Carbapenem Resistance in a Klebsiella pneumoniae Clinical Isolate Is Due to the Combination of blaACT-1 {beta}-Lactamase Production, Porin OmpK35/36 Insertional Inactivation, and Down-Regulation of the Phosphate Transport Porin PhoE.. Antimicrob. Agents Chemother. 50: 3396-3406 [Abstract] [Full Text]  
  • Souli, M., Kontopidou, F. V., Koratzanis, E., Antoniadou, A., Giannitsioti, E., Evangelopoulou, P., Kannavaki, S., Giamarellou, H. (2006). In Vitro Activity of Tigecycline against Multiple-Drug-Resistant, Including Pan-Resistant, Gram-Negative and Gram-Positive Clinical Isolates from Greek Hospitals.. Antimicrob. Agents Chemother. 50: 3166-3169 [Abstract] [Full Text]  
  • Loli, A., Tzouvelekis, L. S., Tzelepi, E., Carattoli, A., Vatopoulos, A. C., Tassios, P. T., Miriagou, V. (2006). Sources of diversity of carbapenem resistance levels in Klebsiella pneumoniae carrying blaVIM-1. J Antimicrob Chemother 58: 669-672 [Abstract] [Full Text]  
  • Kassis-Chikhani, N., Decre, D., Gautier, V., Burghoffer, B., Saliba, F., Mathieu, D., Samuel, D., Castaing, D., Petit, J.-C., Dussaix, E., Arlet, G. (2006). First outbreak of multidrug-resistant Klebsiella pneumoniae carrying blaVIM-1 and blaSHV-5 in a French university hospital. J Antimicrob Chemother 57: 142-145 [Abstract] [Full Text]  
  • Pournaras, S., Ikonomidis, A., Tzouvelekis, L. S., Tokatlidou, D., Spanakis, N., Maniatis, A. N., Legakis, N. J., Tsakris, A. (2005). VIM-12, a Novel Plasmid-Mediated Metallo-{beta}-Lactamase from Klebsiella pneumoniae That Resembles a VIM-1/VIM-2 Hybrid. Antimicrob. Agents Chemother. 49: 5153-5156 [Abstract] [Full Text]  
  • Paterson, D. L., Bonomo, R. A. (2005). Extended-Spectrum {beta}-Lactamases: a Clinical Update. Clin. Microbiol. Rev. 18: 657-686 [Abstract] [Full Text]  
  • Ikonomidis, A., Tokatlidou, D., Kristo, I., Sofianou, D., Tsakris, A., Mantzana, P., Pournaras, S., Maniatis, A. N. (2005). Outbreaks in Distinct Regions Due to a Single Klebsiella pneumoniae Clone Carrying a blaVIM-1 Metallo-{beta}-Lactamase Gene. J. Clin. Microbiol. 43: 5344-5347 [Abstract] [Full Text]  
  • Tortola, M. T., Lavilla, S., Miro, E., Gonzalez, J. J., Larrosa, N., Sabate, M., Navarro, F., Prats, G. (2005). First Detection of a Carbapenem-Hydrolyzing Metalloenzyme in Two Enterobacteriaceae Isolates in Spain. Antimicrob. Agents Chemother. 49: 3492-3494 [Abstract] [Full Text]  
  • Galani, I., Souli, M., Chryssouli, Z., Orlandou, K., Giamarellou, H. (2005). Characterization of a new integron containing blaVIM-1 and aac(6')-IIc in an Enterobacter cloacae clinical isolate from Greece. J Antimicrob Chemother 55: 634-638 [Abstract] [Full Text]  
  • Miriagou, V., Tzelepi, E., Daikos, G. L., Tassios, P. T., Tzouvelekis, L. S. (2005). Panresistance in VIM-1-producing Klebsiella pneumoniae. J Antimicrob Chemother 55: 810-811 [Full Text]  
  • Walsh, T. R., Toleman, M. A., Poirel, L., Nordmann, P. (2005). Metallo-{beta}-Lactamases: the Quiet before the Storm?. Clin. Microbiol. Rev. 18: 306-325 [Abstract] [Full Text]  
  • Lee, K., Yong, D., Yum, J. H., Lim, Y. S., Bolmstrom, A., Qwarnstrom, A., Karlsson, A., Chong, Y. (2005). Evaluation of Etest MBL for Detection of blaIMP-1 and blaVIM-2 Allele-Positive Clinical Isolates of Pseudomonas spp. and Acinetobacter spp.. J. Clin. Microbiol. 43: 942-944 [Abstract] [Full Text]  
  • Conceicao, T., Brizio, A., Duarte, A., Barros, R. (2005). First Isolation of blaVIM-2 in Klebsiella oxytoca Clinical Isolates from Portugal. Antimicrob. Agents Chemother. 49: 476-476 [Full Text]  
  • Giakkoupi, P., Tzouvelekis, L. S., Daikos, G. L., Miriagou, V., Petrikkos, G., Legakis, N. J., Vatopoulos, A. C. (2005). Discrepancies and Interpretation Problems in Susceptibility Testing of VIM-1-Producing Klebsiella pneumoniae Isolates. J. Clin. Microbiol. 43: 494-496 [Abstract] [Full Text]  
  • Lincopan, N., McCulloch, J. A., Reinert, C., Cassettari, V. C., Gales, A. C., Mamizuka, E. M. (2005). First Isolation of Metallo-{beta}-Lactamase-Producing Multiresistant Klebsiella pneumoniae from a Patient in Brazil. J. Clin. Microbiol. 43: 516-519 [Abstract] [Full Text]  
  • Toleman, M. A., Biedenbach, D., Bennett, D. M. C., Jones, R. N., Walsh, T. R. (2005). Italian metallo-{beta}-lactamases: a national problem? Report from the SENTRY Antimicrobial Surveillance Programme. J Antimicrob Chemother 55: 61-70 [Abstract] [Full Text]  
  • Lartigue, M.-F., Poirel, L., Nordmann, P. (2004). First Detection of a Carbapenem-Hydrolyzing Metalloenzyme in an Enterobacteriaceae Isolate in France. Antimicrob. Agents Chemother. 48: 4929-4930 [Full Text]  
  • Luzzaro, F., Docquier, J.-D., Colinon, C., Endimiani, A., Lombardi, G., Amicosante, G., Rossolini, G. M., Toniolo, A. (2004). Emergence in Klebsiella pneumoniae and Enterobacter cloacae Clinical Isolates of the VIM-4 Metallo-{beta}-Lactamase Encoded by a Conjugative Plasmid. Antimicrob. Agents Chemother. 48: 648-650 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Giakkoupi, P.
Right arrow Articles by Vatopoulos, A. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giakkoupi, P.
Right arrow Articles by Vatopoulos, A. C.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»